Faiez Zannad MD, PhD

Prof. Faiez Zannad, MD, PhD, is an internationally recognized heart-failure clinician-scientist and clinical pharmacologist known for transforming cardiovascular medicine. As Professor (Emeritus) of Therapeutics & Cardiology at the University of Lorraine in Nancy, France, he has dedicated his career to improving patient outcomes through pioneering research and leadership. He has led and co-led cornerstone trials like EMPHASIS-HF, RALES, and EPHESUS, which have shaped the global treatment standards for heart failure.

He is also the Founder and Chair of the Global CardioVascular Clinical Trialists (CVCT) Forum — an international think tank connecting regulators, academia, and industry experts across Washington DC, Paris, Asia, and the Middle East. The CVCT Forum is widely recognized as the leading platform for advancing clinical trial methods and innovation in cardiovascular therapeutics.

Trained in Nancy, Lyon, and at the MRC in Oxford, Prof. Zannad has served as Head of the Heart Failure, Hypertension & Preventive Cardiology division at CHU Nancy and continues to inspire new generations of physicians and researchers worldwide through his mentorship, publications, and leadership in major societies such as the ESC and HFA.